FDA Updates
Regulatory announcements & guidance
Stay informed with the latest FDA policy updates, safety alerts,
regulatory guidance, and enforcement actions impacting life sciences.
IP and Exclusivity Updates
Patents, Orange Book & market protection
Track changes to patent listings, exclusivity periods, and
intellectual property developments affecting product lifecycle strategy.
NDA and ANDA Approvals
New drug and generic approvals
Comprehensive coverage of recently approved NDAs and ANDAs,
including sponsor details, indications, and approval timelines.
BLAs & Biosimilars
Biologics and biosimilar pathways
Insights into BLA approvals, biosimilar development progress,
interchangeability status, and regulatory trends.
Partners
